These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8319760)

  • 1. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
    Yayama K; Kawao M; Tujii H; Itoh N; Okamoto H
    Eur J Pharmacol; 1993 May; 236(2):337-8. PubMed ID: 8319760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an angiotensin II receptor antagonist on the progression of renal failure in hyperlipidemic Imai rats.
    Sakemi T; Baba N
    Nephron; 1993; 65(3):426-32. PubMed ID: 8289994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
    Waeber B; Nussberger J; Brunner H
    Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114
    [No Abstract]   [Full Text] [Related]  

  • 4. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F
    Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist.
    Duncia JV; Carini DJ; Chiu AT; Johnson AL; Price WA; Wong PC; Wexler RR; Timmermans PB
    Med Res Rev; 1992 Mar; 12(2):149-91. PubMed ID: 1619965
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
    Sagae Y; Matsumoto Y; Unno K
    J Pharmacobiodyn; 1983 Jul; 6(7):475-80. PubMed ID: 6358456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of saikosaponin-d on aminonucleoside nephrosis in rats.
    Abe H; Orita M; Konishi H; Arichi S; Odashima S
    Eur J Pharmacol; 1986 Jan; 120(2):171-8. PubMed ID: 3948917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc metabolism in aminonucleoside-induced nephrosis.
    Freeman RM; Richards CJ; Rames LK
    Am J Clin Nutr; 1975 Jul; 28(7):699-703. PubMed ID: 1146720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
    Yamanaka M; Tamura Y; Kuribayashi-Okuma E; Uchida S; Shibata S
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F168-F178. PubMed ID: 36454699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
    Shimo T; Adachi Y; Yamanouchi S; Tsuji S; Kimata T; Umezawa K; Okigaki M; Takaya J; Ikehara S; Kaneko K
    Am J Nephrol; 2013; 37(4):302-9. PubMed ID: 23548793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminonucleoside nephrosis in PRO/Re mice.
    Kanwar YS; Manaligod JR; Krakower CA
    Proc Soc Exp Biol Med; 1977 Jul; 155(3):339-45. PubMed ID: 877132
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis.
    Yayama K; Konishi K; Ohta A; Takano M; Ohtani R; Itoh N; Okamoto H
    Nephron; 1993; 63(1):89-93. PubMed ID: 8446257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.